|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0000 - 0.0000|
|52 Week Range|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||4.50|
Spire also said 2018 underlying earnings before interest, taxes, depreciation and amortization (EBITDA) is expected to be in line with 2017. Shares of the company fell 4.4 percent in early trading on the London Stock Exchange. It was in line with Spire's forecast of EBITDA between 149 million pounds to 151 million pounds, which it revised down last year from 162 million pounds, citing weakness in the online NHS referrals business.
South African private hospital group Mediclinic (MDCM.L) (MEIJ.J) does not intend to make another offer for Spire Healthcare (SPI.L), the firm said on Monday after the British company rejected an earlier bid. Spire, in which Mediclinic holds a stake of almost 30 percent, last month rejected a full takeover offer which valued the company at 1.2 billion pounds. Mediclinic had until 1700 GMT on Monday to either make a new offer for Spire or walk away.
Mediclinic shares slipped as much as 6.5 percent to their lowest level since February 2014, while Spire, which has rejected an initial bid, saw its stock drop by more than 7 percent to 276 pence, well below the 298.6 pence offer price. "No agreement has yet been reached on any of the key terms of an offer," Mediclinic, which also reported a 11 percent drop in its first-half profit, said in a statement. Spire rejected Mediclinic's 1.2 billion pound offer last month, saying it "undervalued" Britain's second-largest healthcare company.
Spire said Mediclinic had made a preliminary and conditional proposal that consisted of 150 pence in cash and 0.232 new Mediclinic shares per Spire share, valuing the target at 298.6 pence per share or around 1.2 billion pounds ($1.6 billion) in total. Spire shares were up 13.1 percent at 295.6 pence by 0807 GMT, on track for their biggest-ever daily gain and only a slight discount to the value of Mediclinic's terms.
South African private hospitals operator Mediclinic International (MDCM.L) has approached Spire Healthcare (SPI.L) about a deal to take full control of Britain's second-largest healthcare company, according to a person familiar with the matter. Mediclinic owns 29.9 percent of FTSE 250-listed Spire, a stake it bought for about 430 million pounds from private equity firm Cinven in 2015. The company, which is listed in Johannesburg and London, is now considering a deal to buy the rest of Spire, the person said.